| Product Name | Nebulabio | NBAB-014494 | Anti-Clostridium botulinum botA/BOTOX Nanobody |
|---|---|
| Catalog Number | NBAB-014494 |
| Alias/Synonyms | Botulinum neurotoxin type A, BoNT/A, Bontoxilysin-A, BOTOX, Botulinum neurotoxin A light chain, LC, 3.4.24.69, Botulinum neurotoxin A heavy chain, HC, botA, bna, CBO0806, CLC_0862 |
| Appearance | See COA |
| Molecule Weight | N/A |
| CAS | N/A |
| Solubility | N/A |
| Storage | Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles. |
| Shelf Life | See COA |
| Additional info 1 | Ship with Ice Pack. |
| Additional info 2 | For Research Use Only. |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBAB-014494 | 100ul; 500ul; 1ml | Inquire | In Stock |
Nebulabio | NBAB-014494 | Anti-Clostridium botulinum botA/BOTOX Nanobody
Product Name:NebuSelect™ Anti-Clostridium botulinum botA/BOTOX Nanobody
Catalog Number:NBAB-014494
Size:100ul; 500ul; 1ml; Bulk
Brand:Nebulabio
Description:
NebuSelect™ Anti-Clostridium botulinum botA/BOTOX Nanobody (Cat# NBAB-014494) was produced in alpacas immunized with recombinant Clostridium botulinum botA protein, and it reacts with Clostridium botulinum. This antibody is validated for Flow Cytometry.
| Reactivity | Clostridium botulinum |
| Specificity | Clostridium botulinum botA |
| Immunogen | Recombinant Clostridium botulinum botA protein |
| Isotype | Monoclonal Alpaca IgG |
| Purification | Protein A & Protein G Affinity Purification |
| Buffer | 0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol. |
| Conjugate | Unconjugated |
| Applications | Flow Cytometry |
| Dilution | FC:1:20～1:200 |
| Storage & Shipment | This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃. |
